WHO nod for Covaxin likely this month

New Delhi: The World Health Organization’s approval for the indigenous Covid-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.

“The WHO approval for Covaxin is likely this month,” an official source said. PTI

  • Related Posts

    Sun Pharma recalls over 1900 bottles of epilepsy drug in US

    According to the US FDA’s latest enforcement report, the recall was initiated after black spots were found on the tablets due to burnt excipient used for manufacturing. New Delhi: Sun…

    Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

    New Delhi: The Delhi Police Crime Branch has busted an alleged illegal network involved in the smuggling, adulteration and distribution of counterfeit and unauthorised anti-cancer and other life-saving medicines in the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma recalls over 1900 bottles of epilepsy drug in US

    Sun Pharma recalls over 1900 bottles of epilepsy drug in US

    Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

    Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

    Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

    Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

    Meiji Seika to push new vaccine with SII in India

    Meiji Seika to push new vaccine with SII in India

    DGFT automates EO extension process to ease compliance for pharma exporters

    DGFT automates EO extension process to ease compliance for pharma exporters

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark